Alendronic acid
- PDF / 169,148 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 51 Downloads / 178 Views
1
Alendronic acid Muscle and joint pain: case report In a study involving 50 patients, a patient [age and sex not stated] was described, who experienced joint and muscle pain while receiving alendronic acid for osteoporosis. The patient, who had osteoporosis with chronic kidney disease, started receiving oral alendronic acid [alendronate] 70mg tablet once every week for 6 weeks. Subsequently, the patient experienced joint and muscle pain; however, alendronic acid was not discontinued [duration of treatment to reaction onset and outcome not stated]. Author comment: "[O]ne patient experienced muscle and joint pain as an adverse effect." Aggarwal HK, et al. Effects of Short Term Alendronate Administration on Bone Mineral Density in Patients with Chronic Kidney Disease. Prilozi Makedonska Akademija Na Naukite I Umetnostite Oddelenie Za Medicinski Nauki 39: 5-13, No. 1, 13 Aug 2018. Available from: URL: http://doi.org/10.2478/ 803433007 prilozi-2018-0019 - India
0114-9954/19/1778-0001/$14.95 Adis © 2019 Springer Nature Switzerland AG. All rights reserved
Reactions 9 Nov 2019 No. 1778
Data Loading...
